Bupivacaine hydrochloride; epinephrine - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for bupivacaine hydrochloride; epinephrine and what is the scope of freedom to operate?
Bupivacaine hydrochloride; epinephrine
is the generic ingredient in five branded drugs marketed by Hospira, Fresenius Kabi Usa, and Septodont, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.Two suppliers are listed for this compound.
Summary for bupivacaine hydrochloride; epinephrine
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 3 |
NDAs: | 14 |
Finished Product Suppliers / Packagers: | 2 |
Clinical Trials: | 167 |
DailyMed Link: | bupivacaine hydrochloride; epinephrine at DailyMed |
Recent Clinical Trials for bupivacaine hydrochloride; epinephrine
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Montefiore Medical Center | N/A |
University Hospital "Sestre Milosrdnice" | N/A |
Jessyka Lighthall | Phase 3 |
See all bupivacaine hydrochloride; epinephrine clinical trials
Pharmacology for bupivacaine hydrochloride; epinephrine
Drug Class | Amide Local Anesthetic Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Physiological Effect | Local Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for bupivacaine hydrochloride; epinephrine
US Patents and Regulatory Information for bupivacaine hydrochloride; epinephrine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | bupivacaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 016964-013 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Fresenius Kabi Usa | SENSORCAINE | bupivacaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 018304-004 | Sep 2, 1983 | AP | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Fresenius Kabi Usa | SENSORCAINE | bupivacaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 018304-005 | Sep 2, 1983 | AP | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hospira | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | bupivacaine hydrochloride; epinephrine | INJECTABLE;INJECTION | 071168-001 | Jun 16, 1988 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Fresenius Kabi Usa | SENSORCAINE | bupivacaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 070968-001 | Oct 13, 1987 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hospira | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | bupivacaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 016964-010 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.